re: IBM Watson Helps Doctors Fight Cancer
The apps look promising, but the $2 trillion healthcare industry attracts lots of vendors. SAS and Pegasystems both play in this arena. The key question is whether their analytics and rules-driven systems, respectively, are designed to keep learning the way Watson constantly ingests the latest research and clinical trial information. Rules tend to be brittle and analytics models are only as up to date as the last training set. Seems like Watson would have an advantage if it truly keeps up on a steady diet of fresh information as claimed.